Genmab — Marts 2017
-
Janssen har indtil 7. april til at komme med indvendinger til NICE. Derefter nyt møde 20. april. https://www.nice.org.uk/guidance/indevelopment/GID-TA10076/consultation/html-content
-
I øvrigt pudsigt, at NICE betragter pomalidomid som et seriøst alternativ til dara. Her i lander overvejer KRIS at tilbagekalde anbefalingen af pom http://haematologisktidsskrift.dk/sygdomme/myeloma/206-kris-overvejer-tilbagekaldelse-af-pomalidomid.html
-
Lidt Gen teknisk. https://sherwooddaily.com/genmab-as-gmxay-needle-moving-3-85/55909/
-
http://www.ouh.dk/wm478383 forsøg nr. 10
-
God morgen.

-
Er dette et nyt studie der skal startes op. ? https://clinicaltrials.gov/ct2/show/NCT02477891
-
Heller ikke set disse priser før på Dara.? http://www.myelomacrowd.org/daratumumab-darzalex-financial-assistance-program/
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind